Since miR-24-3 inhibition did not affect the expression of MT1JP (Fig. S4C), we first analyzed the relation between cell viability in response to Lenvatinib exposure and relative miR-24-3p expression in the HCC cells and found that miR-24-3p overexpression decreased the viability of Lenvatinib treated LR-HCC cells (Fig. S4D). The gene discussed is MT1JP; the disease is hepatocellular carcinoma.